Outcome of Ocular Steroid Hypertensive Response in Children

Savleen Kaur1, Indu Dhiman, Sushmita Kaushik

  • 1Advanced Eye Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, India.

Journal of Glaucoma
|February 5, 2015
PubMed

Insights

Steroid-induced ocular hypertension in children is a significant concern, but withdrawing steroids and using glaucoma medications effectively controlled high intraocular pressure in most cases. Early intervention and alternative treatments can prevent long-term vision damage.

Area of Science:

  • Ophthalmology
  • Pediatric Glaucoma
  • Steroid-induced Ocular Hypertension

Background:

  • Steroid use in children can lead to ocular hypertension, a condition characterized by elevated intraocular pressure (IOP).
  • Understanding the epidemiological profile and outcomes of this condition is crucial for effective management in pediatric populations.

Purpose of the Study:

  • To analyze the epidemiological characteristics and treatment outcomes of steroid-induced ocular hypertension in children under 12 years old.
  • To identify risk factors and effective management strategies for pediatric steroid-induced ocular hypertension.

Main Methods:

  • Retrospective review of hospital records of pediatric glaucoma patients from July 2005 to December 2012.
  • Definition of steroid-induced ocular hypertension: IOP > 21 mm Hg or > 6 mm Hg increase from baseline, with or without glaucomatous optic neuropathy.
  • Data collected included demographics, steroid use, management details, and IOP control.

Main Results:

  • Steroid-induced ocular hypertension accounted for 24% of pediatric glaucoma cases (36 of 150 patients).
  • The mean age of affected children was 9.2 ± 2.4 years, with 22 patients showing a bilateral response.
  • Steroid withdrawal alone managed 16 patients, medical therapy controlled 13, and 7 required surgery. Favorable IOP control (<21 mm Hg) was achieved in 80.5% of cases.

Conclusions:

  • Steroid-induced ocular hypertension is a notable side effect in pediatric patients.
  • Non-steroidal anti-inflammatory alternatives should be considered to avoid steroid use when possible.
  • Withdrawal of steroids and appropriate medical management are effective in controlling IOP in the majority of affected children.
Abstract

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.7K
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.7K
Ophthalmic Drug Delivery Systems01:23

Ophthalmic Drug Delivery Systems

Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
252
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.7K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
798